Compagnie Lombard Odier S Cm A Qiagen N.V. Transaction History

Compagnie Lombard Odier S Cm A

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$45.29 - $50.76 $648,416 - $726,730	-14,317 Reduced 34.74%	26,900 $1.24 Million
Q4 2022 Feb 13, 2023	BUY	$41.91 - $50.48 $51,968 - $62,595	1,240 Added 3.1%	41,217 $2.07 Million
Q1 2022 Apr 27, 2022	SELL	$42.23 - $54.3 $751,694 - $966,540	-17,800 Reduced 30.81%	39,977 $1.98 Million
Q4 2018 Feb 13, 2019	BUY	$32.65 - $37.95 $1.89 Million - $2.19 Million	57,777 New	57,777 $1.96 Million
Q1 2018 May 11, 2018	SELL	$31.01 - $34.72 $85,277 - $95,480	-2,750 Closed	0 $0

Q4 2017 Feb 16, 2018	SELL	$30.68 - $35.37 $49.1 Million - $56.6 Million	-1,600,000 Reduced 99.83%	2,750 $86,000
Q4 2017 Feb 13, 2018	BUY	$30.68 - $35.37 $49.2 Million - $56.7 Million	1,602,750	1,602,750 $1.84 Million

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.